4.7 Article

Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment

Jean-Pierre Jourdan et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Multidisciplinary Sciences

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Cedric Lecoutey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Clinical Neurology

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

Jeffrey L. Cummings et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Article Chemistry, Medicinal

Identification of Multiple 5-HT4 Partial Agonist Clinical Candidates for the Treatment of Alzheimer's Disease

Michael A. Brodney et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Chemistry, Medicinal

Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands

Jonah Cheung et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Synthesis of dual AChE/5-HT4 receptor multi-target directed ligands

Cedric Lecoutey et al.

MEDCHEMCOMM (2012)

Article Chemistry, Medicinal

Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators

Weiguo Liu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Correction Clinical Neurology

Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)

F. Mangialasche et al.

LANCET NEUROLOGY (2011)

Article Chemistry, Organic

A Divergent and Selective Synthesis of Isomeric Benzoxazoles from a Single N-Cl Imine

Cheng-yi Chen et al.

ORGANIC LETTERS (2011)

Article Chemistry, Organic

Copper-catalyzed cyclization of Z-oximes into 3-methyl-1,2-benzisoxazoles

Sandra Udd et al.

TETRAHEDRON LETTERS (2010)

Review Clinical Neurology

Alzheimer's disease: clinical trials and drug development

Francesca Mangialasche et al.

LANCET NEUROLOGY (2010)

Review Genetics & Heredity

Genetic aspects of Alzheimer disease

Thomas D. Bird

GENETICS IN MEDICINE (2008)

Review Chemistry, Medicinal

Multi-target-directed ligands to combat neurodegenerative diseases

Andrea Cavalli et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Clinical Neurology

Potent beta-amyloid modulators

E. Garcia-Palomero et al.

NEURODEGENERATIVE DISEASES (2008)

Article Neurosciences

5-HT4 receptors: History, molecular pharmacology and brain functions

Joel Bockaert et al.

NEUROPHARMACOLOGY (2008)

Review Chemistry, Medicinal

Designed multiple ligands. An emerging drug discovery paradigm

R Morphy et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

Article Pharmacology & Pharmacy

New insights into the human 5-HT4 receptor binding site:: exploration of a hydrophobic pocket

L Rivail et al.

BRITISH JOURNAL OF PHARMACOLOGY (2004)